Interaction between riluzole treatment and dietary glycemic index in the disease progression of amyotrophic lateral sclerosis
High dietary GI and GL are associated with a slower functional decline only among ALS patients taking riluzole.
Authors
- Ikjae Lee (ORCID: https://orcid.org/0000-0003-0537-9622)
- Jeri W. Nieves (ORCID: https://orcid.org/0000-0001-8593-343X)
- Seonjoo Lee (ORCID: https://orcid.org/0000-0003-3177-6357)
- Pam Factor‐Litvak (ORCID: https://orcid.org/0000-0002-7729-1884)
- Edward J. Kasarskis (ORCID: https://orcid.org/0000-0001-5584-7506)
- Hiroshi Mitsumoto (ORCID: https://orcid.org/0000-0001-6259-8923)
- Michael Rosenbaum (ORCID: https://orcid.org/0000-0002-8908-9448)
Institutions
- University of Kentucky (US)
- Columbia University Irving Medical Center (US)
- Columbia University (US)
Publication Details
- Journal
- Annals of Clinical and Translational Neurology
- Published
- 2025-01-09
- DOI
- https://doi.org/10.1002/acn3.52294
- Citations
- 1
- Primary Topic
- Amyotrophic Lateral Sclerosis Research
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- National Institute of Neurological Disorders and Stroke